A trial to check the effect of Capsule and syrup Shwasi in the management of Shwas Roga w.s.r. to Bronchial Asthma.

A clinical study to evaluate the efficacy and safety of ayurvedic formulations (Capsule and syrup Shwasi) in the management of Tamak Shwas w.s.r. to Bronchial Asthma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/01/011184

Enrollment

Registered

2018-01-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with Episodic Bronchial Asthma

Interventions

Intervention1: Cap Shwasi and Syrup Shwasi: group 1- 2 Capsule(500mg) TID with water for 30 days group2- 10 ml TID + 2 Capsules(500mg) TID with water for 30 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing for trial. 2. Age between 20 -60 years of either sex. 3. Patients presenting with clinical features of Tamak Shwas/Bronchial Asthma with impaired PFT.

Exclusion criteria

Exclusion criteria: 1. Patients not willing for the trial or not ready to give informed consent. 2. Patients of age 3. Patients with Uncontrolled Hypertension and Diabetes mellitus with complications. 4. Patients having malignancy, chronic cardiac illness, hepatic disorders, renal disorders, tuberculosis and other comorbid diseases.

Design outcomes

Primary

Measure	Time frame
awaitedTimepoint: after every 15 days till completion of the trial	—

Secondary

Measure	Time frame
awaitedTimepoint: every 15 days after initiating the therapy till completion of the trial	—

Countries

India

Contacts

Public ContactProf B L Mehra

rajiv gandhi govt post graduate ayurvedic college and hoapital Paprola

mehra_bl@rediffmail.com9418017615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026